JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120
Citigroup Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $117
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $125
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $107
Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $113
Loading...